Copyright
©The Author(s) 2004.
World J Gastroenterol. Dec 15, 2004; 10(24): 3666-3669
Published online Dec 15, 2004. doi: 10.3748/wjg.v10.i24.3666
Published online Dec 15, 2004. doi: 10.3748/wjg.v10.i24.3666
Table 2 Clinical outcomes of pantoprazole and ranitidine groups n (%)
| Pantoprazole group (n = 52) | Ranitidine group (n = 50) | P | |
| Rebleeding | 2 (3.8) | 8 (16.0) | 0.041 |
| Emergency operation | 0 (0.0) | 1 (2.0) | 0.31 |
| Hospital days (SD) | 5.9 (3.2) | 7.5 (5.0) | 0.06 |
| Units of Blood transfusion (SD) | 4.9 (5.8) | 5.7 (6.8) | 0.42 |
| Mortality | 1 (1.9) | 1 (2.0) | 1.00 |
- Citation: Hsu PI, Lo GH, Lo CC, Lin CK, Chan HH, Wu CJ, Shie CB, Tsai PM, Wu DC, Wang WM, Lai KH. Intravenous pantoprazole versus ranitidine for prevention of rebleeding after endoscopic hemostasis of bleeding peptic ulcers. World J Gastroenterol 2004; 10(24): 3666-3669
- URL: https://www.wjgnet.com/1007-9327/full/v10/i24/3666.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i24.3666